The agenda for the 29 April 2015 TC meeting is now available. The Commission will consider the following technologies:

• Nintedanib (Ofev) - new medicine
• Ramucirumab (Cyramza) - new medicine
• Ketoconazole (Ketoconazole HRA) - new formulation
• Abiraterone acetate (Zytiga) - review of ASMR
• Tiotropium bromide monohydrate (Spiriva Respimat) - new indication
• Influenza vaccine (quadrivalent) (Fluarix Tetra) - new vaccine

For more details, go to: http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-04/odj_ct_29042015_internet.pdf [French]